BioMarin Pharmaceutical Inc - SWOT Analysis
| Publication Date | February 2008 |
|---|---|
| Publisher | Datamonitor |
| Product Type | Report |
| Pages | 33 |
| ISBN Number | not applicable |
| Product Code | DAT06591 |
Summary
Datamonitor's BioMarin Pharmaceutical Inc Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
BioMarin Pharmaceutical (BioMarin) is engaged in development and commercialization of biopharmaceuticals. The company select product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market. The company primarily operates in the US. It is headquartered in Novato, California and employs about 400 people. The company recorded revenues of $84.2 million during the fiscal year ended December 2006, as compared to the revenues of an increase of $25.6 million in 2005. The operating loss of the company was $24.7 million during fiscal year 2006 as compared to the operating loss of $64.2 million in 2005. The net loss was $28.5 million in fiscal year 2006 as compared to the net loss of $74.3 million in 2005.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available
Content
- Key Facts
- Company Overview
- Business Description
- Company History
- Key Employees
- Key Employee Biographies
- Company View
- SWOT analysis
- Products & Services Listing
- Products & Services Analysis
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















